Mi mesa cojea

101 Lugares increíbles - Sentado frente al Mundo La media hostia Prostate cancer drug so effective trial stopped A new drug for advanced prostate cancer patients has proved so effective that researchers stopped the clinical trial early to give all patients a chance to receive the life-extending medication, according to a UCSF-led study released Saturday. The hormone treatment, Johnson & Johnson's Zytiga, when added to a standard steroid therapy doubled the time it takes for the disease to progress in patients treated with the standard therapy alone, said the lead researcher, Dr. Charles Ryan, associate professor of clinical medicine at the UCSF Helen Diller Family Comprehensive Cancer Center. The U.S. Food and Drug Administration last year approved Zytiga, also known as abiraterone, for use in men whose prostate cancer had spread to other parts of their body and had already been treated with chemotherapy. The FDA will have to approve it for patients who have not had chemotherapy before it can be marketed for broader use. A treatable disease Hopeful drug for many Dr.

EDICIONES OBELISCO Venta de Libros de psicología, pedagogía, educación, autoayuda, divulgación, espiritualidad, religión, esoterismo, magia, ocultismo, narrativa, infantil, salud, Books of psychology, pedagogy, education, self-help, spreading, spirit